ArticlePeerJ2025

A combination of hepatic leukemia factor and circulating tumor cells serve as effective biomarkers for lung adenocarcinoma prognosis.

Yaofeng Zhi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.